IBDEI2I6 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,39966,0)
;;=N30.90^^152^2002^20
;;^UTILITY(U,$J,358.3,39966,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39966,1,3,0)
;;=3^Cystitis w/o Hematuria,Unspec
;;^UTILITY(U,$J,358.3,39966,1,4,0)
;;=4^N30.90
;;^UTILITY(U,$J,358.3,39966,2)
;;=^5015642
;;^UTILITY(U,$J,358.3,39967,0)
;;=N41.9^^152^2002^38
;;^UTILITY(U,$J,358.3,39967,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39967,1,3,0)
;;=3^Inflammatory Disease of Prostate,Unspec
;;^UTILITY(U,$J,358.3,39967,1,4,0)
;;=4^N41.9
;;^UTILITY(U,$J,358.3,39967,2)
;;=^5015694
;;^UTILITY(U,$J,358.3,39968,0)
;;=N70.91^^152^2002^75
;;^UTILITY(U,$J,358.3,39968,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39968,1,3,0)
;;=3^Salpingitis,Unspec
;;^UTILITY(U,$J,358.3,39968,1,4,0)
;;=4^N70.91
;;^UTILITY(U,$J,358.3,39968,2)
;;=^5015806
;;^UTILITY(U,$J,358.3,39969,0)
;;=N70.93^^152^2002^74
;;^UTILITY(U,$J,358.3,39969,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39969,1,3,0)
;;=3^Salpingitis & Oophoritis,Unspec
;;^UTILITY(U,$J,358.3,39969,1,4,0)
;;=4^N70.93
;;^UTILITY(U,$J,358.3,39969,2)
;;=^5015808
;;^UTILITY(U,$J,358.3,39970,0)
;;=N70.92^^152^2002^55
;;^UTILITY(U,$J,358.3,39970,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39970,1,3,0)
;;=3^Oophoritis,Unspec
;;^UTILITY(U,$J,358.3,39970,1,4,0)
;;=4^N70.92
;;^UTILITY(U,$J,358.3,39970,2)
;;=^5015807
;;^UTILITY(U,$J,358.3,39971,0)
;;=N73.9^^152^2002^37
;;^UTILITY(U,$J,358.3,39971,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39971,1,3,0)
;;=3^Inflammatory Disease Female Pelvic,Unspec
;;^UTILITY(U,$J,358.3,39971,1,4,0)
;;=4^N73.9
;;^UTILITY(U,$J,358.3,39971,2)
;;=^5015820
;;^UTILITY(U,$J,358.3,39972,0)
;;=A56.11^^152^2002^36
;;^UTILITY(U,$J,358.3,39972,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39972,1,3,0)
;;=3^Inflammatory Disease Chlamydial Female Pelvic
;;^UTILITY(U,$J,358.3,39972,1,4,0)
;;=4^A56.11
;;^UTILITY(U,$J,358.3,39972,2)
;;=^5000342
;;^UTILITY(U,$J,358.3,39973,0)
;;=N73.5^^152^2002^64
;;^UTILITY(U,$J,358.3,39973,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39973,1,3,0)
;;=3^Peritonitis Female Pelvic,Unspec
;;^UTILITY(U,$J,358.3,39973,1,4,0)
;;=4^N73.5
;;^UTILITY(U,$J,358.3,39973,2)
;;=^5015817
;;^UTILITY(U,$J,358.3,39974,0)
;;=N72.^^152^2002^35
;;^UTILITY(U,$J,358.3,39974,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39974,1,3,0)
;;=3^Inflammatory Disease Cervix Uteri
;;^UTILITY(U,$J,358.3,39974,1,4,0)
;;=4^N72.
;;^UTILITY(U,$J,358.3,39974,2)
;;=^5015812
;;^UTILITY(U,$J,358.3,39975,0)
;;=N76.3^^152^2002^92
;;^UTILITY(U,$J,358.3,39975,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39975,1,3,0)
;;=3^Vulvitis,Subacute & Chronic
;;^UTILITY(U,$J,358.3,39975,1,4,0)
;;=4^N76.3
;;^UTILITY(U,$J,358.3,39975,2)
;;=^5015829
;;^UTILITY(U,$J,358.3,39976,0)
;;=N76.1^^152^2002^88
;;^UTILITY(U,$J,358.3,39976,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39976,1,3,0)
;;=3^Vaginitis,Subacute & Chronic
;;^UTILITY(U,$J,358.3,39976,1,4,0)
;;=4^N76.1
;;^UTILITY(U,$J,358.3,39976,2)
;;=^5015827
;;^UTILITY(U,$J,358.3,39977,0)
;;=N76.2^^152^2002^91
;;^UTILITY(U,$J,358.3,39977,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39977,1,3,0)
;;=3^Vulvitis,Acute
;;^UTILITY(U,$J,358.3,39977,1,4,0)
;;=4^N76.2
;;^UTILITY(U,$J,358.3,39977,2)
;;=^5015828
;;^UTILITY(U,$J,358.3,39978,0)
;;=N76.0^^152^2002^87
;;^UTILITY(U,$J,358.3,39978,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2I6 3765 printed Apr 09, 2024@21:46:09 Page 2
IBDEI2I6 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,39966,0)
+2 ;;=N30.90^^152^2002^20
+3 ;;^UTILITY(U,$J,358.3,39966,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,39966,1,3,0)
+6 ;;=3^Cystitis w/o Hematuria,Unspec
+7 ;;^UTILITY(U,$J,358.3,39966,1,4,0)
+8 ;;=4^N30.90
+9 ;;^UTILITY(U,$J,358.3,39966,2)
+10 ;;=^5015642
+11 ;;^UTILITY(U,$J,358.3,39967,0)
+12 ;;=N41.9^^152^2002^38
+13 ;;^UTILITY(U,$J,358.3,39967,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,39967,1,3,0)
+16 ;;=3^Inflammatory Disease of Prostate,Unspec
+17 ;;^UTILITY(U,$J,358.3,39967,1,4,0)
+18 ;;=4^N41.9
+19 ;;^UTILITY(U,$J,358.3,39967,2)
+20 ;;=^5015694
+21 ;;^UTILITY(U,$J,358.3,39968,0)
+22 ;;=N70.91^^152^2002^75
+23 ;;^UTILITY(U,$J,358.3,39968,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,39968,1,3,0)
+26 ;;=3^Salpingitis,Unspec
+27 ;;^UTILITY(U,$J,358.3,39968,1,4,0)
+28 ;;=4^N70.91
+29 ;;^UTILITY(U,$J,358.3,39968,2)
+30 ;;=^5015806
+31 ;;^UTILITY(U,$J,358.3,39969,0)
+32 ;;=N70.93^^152^2002^74
+33 ;;^UTILITY(U,$J,358.3,39969,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,39969,1,3,0)
+36 ;;=3^Salpingitis & Oophoritis,Unspec
+37 ;;^UTILITY(U,$J,358.3,39969,1,4,0)
+38 ;;=4^N70.93
+39 ;;^UTILITY(U,$J,358.3,39969,2)
+40 ;;=^5015808
+41 ;;^UTILITY(U,$J,358.3,39970,0)
+42 ;;=N70.92^^152^2002^55
+43 ;;^UTILITY(U,$J,358.3,39970,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,39970,1,3,0)
+46 ;;=3^Oophoritis,Unspec
+47 ;;^UTILITY(U,$J,358.3,39970,1,4,0)
+48 ;;=4^N70.92
+49 ;;^UTILITY(U,$J,358.3,39970,2)
+50 ;;=^5015807
+51 ;;^UTILITY(U,$J,358.3,39971,0)
+52 ;;=N73.9^^152^2002^37
+53 ;;^UTILITY(U,$J,358.3,39971,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,39971,1,3,0)
+56 ;;=3^Inflammatory Disease Female Pelvic,Unspec
+57 ;;^UTILITY(U,$J,358.3,39971,1,4,0)
+58 ;;=4^N73.9
+59 ;;^UTILITY(U,$J,358.3,39971,2)
+60 ;;=^5015820
+61 ;;^UTILITY(U,$J,358.3,39972,0)
+62 ;;=A56.11^^152^2002^36
+63 ;;^UTILITY(U,$J,358.3,39972,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,39972,1,3,0)
+66 ;;=3^Inflammatory Disease Chlamydial Female Pelvic
+67 ;;^UTILITY(U,$J,358.3,39972,1,4,0)
+68 ;;=4^A56.11
+69 ;;^UTILITY(U,$J,358.3,39972,2)
+70 ;;=^5000342
+71 ;;^UTILITY(U,$J,358.3,39973,0)
+72 ;;=N73.5^^152^2002^64
+73 ;;^UTILITY(U,$J,358.3,39973,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,39973,1,3,0)
+76 ;;=3^Peritonitis Female Pelvic,Unspec
+77 ;;^UTILITY(U,$J,358.3,39973,1,4,0)
+78 ;;=4^N73.5
+79 ;;^UTILITY(U,$J,358.3,39973,2)
+80 ;;=^5015817
+81 ;;^UTILITY(U,$J,358.3,39974,0)
+82 ;;=N72.^^152^2002^35
+83 ;;^UTILITY(U,$J,358.3,39974,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,39974,1,3,0)
+86 ;;=3^Inflammatory Disease Cervix Uteri
+87 ;;^UTILITY(U,$J,358.3,39974,1,4,0)
+88 ;;=4^N72.
+89 ;;^UTILITY(U,$J,358.3,39974,2)
+90 ;;=^5015812
+91 ;;^UTILITY(U,$J,358.3,39975,0)
+92 ;;=N76.3^^152^2002^92
+93 ;;^UTILITY(U,$J,358.3,39975,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,39975,1,3,0)
+96 ;;=3^Vulvitis,Subacute & Chronic
+97 ;;^UTILITY(U,$J,358.3,39975,1,4,0)
+98 ;;=4^N76.3
+99 ;;^UTILITY(U,$J,358.3,39975,2)
+100 ;;=^5015829
+101 ;;^UTILITY(U,$J,358.3,39976,0)
+102 ;;=N76.1^^152^2002^88
+103 ;;^UTILITY(U,$J,358.3,39976,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,39976,1,3,0)
+106 ;;=3^Vaginitis,Subacute & Chronic
+107 ;;^UTILITY(U,$J,358.3,39976,1,4,0)
+108 ;;=4^N76.1
+109 ;;^UTILITY(U,$J,358.3,39976,2)
+110 ;;=^5015827
+111 ;;^UTILITY(U,$J,358.3,39977,0)
+112 ;;=N76.2^^152^2002^91
+113 ;;^UTILITY(U,$J,358.3,39977,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,39977,1,3,0)
+116 ;;=3^Vulvitis,Acute
+117 ;;^UTILITY(U,$J,358.3,39977,1,4,0)
+118 ;;=4^N76.2
+119 ;;^UTILITY(U,$J,358.3,39977,2)
+120 ;;=^5015828
+121 ;;^UTILITY(U,$J,358.3,39978,0)
+122 ;;=N76.0^^152^2002^87
+123 ;;^UTILITY(U,$J,358.3,39978,1,0)
+124 ;;=^358.31IA^4^2
